Bentley-based biotech company Recce has popped the cork on its first day of trading on the ASX, following completion of a $5 million initial public offering.
A Bentley biotech company led by Graham Melrose is planning a $5 million initial public offering, after six years of research on the development of synthetic antibiotics.
Rockingham-based veterinary pharmaceuticals manufacturer Chemeq Ltd has seen a 50 per cent jump in its share price following the announcement today that founder Graham Melrose had quit his stake in the company.
THE founder of animal drug company Chemeq Ltd, Dr Graham Melrose, has retired as a non-executive director. Dr Melrose had been involved with Chemeq since it was founded in 1989.
The past year has been a tough stretch for Chemeq shareholders, but executive chairman Graham Melrose is adamant the company is on the right track. Mark Beyer reports.
